Net Cash Provided by (Used in) Operating Activities |
65.3K |
USD |
+82.8% |
Mar 31, 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
600K |
shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.64M |
USD |
-40.1% |
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
1.04M |
USD |
+31.3% |
Dec 31, 2022 |
Q4 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Gross |
1.04M |
USD |
+31.2% |
Dec 31, 2022 |
Q4 2022 |
Depreciation |
2.57K |
USD |
-5.96% |
Mar 31, 2023 |
Q1 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.02M |
USD |
+30.6% |
Dec 31, 2022 |
Q4 2022 |
Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Additional Paid in Capital |
53.9M |
USD |
0% |
Sep 30, 2023 |
Q3 2023 |
Current State and Local Tax Expense (Benefit) |
9.37K |
USD |
+1195% |
Dec 31, 2022 |
Q4 2022 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
2.94K |
USD |
0% |
Dec 31, 2022 |
Q4 2022 |
Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |